FDA Import Refusal AEK-4939022-0/41/1 — Glaxosmithkline
The FDA refused shipment AEK-4939022-0/41/1 from Glaxosmithkline (United Kingdom) on Apr 1, 2024. The refused product falls under Drugs and Biologics — ANTIBIOTIC N.E.C.. Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 1, 2024
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 56YDA99 ANTIBIOTIC N.E.C.
- Charges
- 118,75